Sutro Biopharma Inc share price logo

Sutro Biopharma Inc Share Price

NASDAQ: STRO

Small Cap

$23.72

-1.15

(-4.62%)

as on

Sutro Biopharma Inc Stock Performance

as on April 3, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $23.65
    $25.39
    downward going graph

    0.30%

    Downside

    7.04%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $5.23
    $26.54
    downward going graph

    77.95%

    Downside

    11.89%

    Upside

    downward going graph

Sutro Biopharma Inc share price movements today

Previous Close
$24.87
Open
$24.15
Volume
267.9K
Day's Low - High
$23.65 - $25.39
52 Week Low - High
$5.23 - $26.54

Sutro Biopharma Inc Historical Returns

1 Month Return
-5.97 %
3 Month Return
+ 106.42 %
1 Year Return
+ 338.66 %
3 Year Return
-48.19 %
5 Year Return
-89.57 %

Sutro Biopharma Inc Stock Fundamentals & Key Indicators

Check Sutro Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$394.0M

EPS (TTM)

-6.71

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.98

Industry PE ratio

-3.9087227414330217

PEG Ratio

0

EBITDA

-97.6M

Revenue (TTM)

102.5M

Profit Margin

-186.45%

Return On Equity TTM

-1810.01%

Sutro Biopharma Inc Stock Valuation

Track how Sutro Biopharma Inc P/E has moved over time to understand its valuation trends.

Sutro Biopharma Inc in the last 5 years

  • Overview

  • Trends

Lowest (-107.54x)

June 30, 2021

Industry (-3.91x)

April 6, 2026

Today (-2.98x)

April 6, 2026

Highest (-1.32x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -2.98x

Sutro Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sutro Biopharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Sutro Biopharma Inc image
Sutro Biopharma Inc
BUY$394.0M-89.57%-2.98-186.45%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$42.3B124.53%136.858.45%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$35.7BNA126.855.37%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$111.4B103.77%28.6632.94%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.5B59.16%18.3831.41%

Stock Returns calculator for Sutro Biopharma Inc Stock including INR - Dollar returns

The Sutro Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Sutro Biopharma Inc investment value today

Current value as on today

₹4,72,231

Returns

₹3,72,231

(+372.23%)

Returns from Sutro Biopharma Inc Stock

₹3,37,638 (+337.64%)

Dollar Impact

₹34,593 (+34.59%)

Analyst Recommendation on Sutro Biopharma Inc Stock

Based on 16 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Sutro Biopharma Inc. Average target price of $29.12

Sutro Biopharma Inc Share Price Target

Get share price movements and forecasts by analysts on Sutro Biopharma Inc.

What analysts predicted

18.54%UPSIDE

Target Price

$29.12

Current Price

$23.72

Analyzed by

16 Analysts

Target

$29.12

Sutro Biopharma Inc target price $29.12, a slight upside of 18.54% compared to current price of $23.72. According to 16 analysts rating.

Sutro Biopharma Inc Stock’s Investor Sentiment and Interest

Search interest for Sutro Biopharma Inc Stock has increased by 54% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:54% versus previous 30 day period

Sutro Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
16
113
13
25
8
14
17
63
9
11
Gross Profit
16
113
11
23
8
14
17
63
9
10
Operating Income
-44
43
-56
-48
-67
-65
-68
-3
-48
-33
EBITDA
-37
57
-49
-38
-39
-59
-45
1
-44
-32
Interest Expense
8
8
9
9
7
8
10
9
10
9
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-47
46
-58
-48
-48
-70
-75
-11
-56
-46
Income Tax Expense
1
15
1
0
-
2
-
0
-
0
Net Income
-49
31
-58
-48
-48
-72
-75
-11
-56
-46
Net Profit Margin
-291.21%
27.32%
-447.52%
-186.80%
-572.62%
-489.18%
-436.62%
-18.04%
-586.58%
-401.49%

Sutro Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
59
51
38
42
42
61
67
153
62
102
Gross Profit
16
0
-15
42
-34
52
59
146
54
95
Operating Income
1
-19
-37
-55
-71
-98
-128
-89
-238
-104
EBITDA
7
-14
-32
-46
-23
-97
-105
-67
-180
-97
Interest Expense
-
0
1
4
3
3
3
23
31
38
Depreciation
-
4
4
4
4
4
5
6
7
7
Income Before Tax
1
-19
-35
-55
-32
-105
-116
-88
-225
-191
Income Tax Expense
0
0
3
8
4
3
2
18
2
0
Net Income
1
-19
-35
-55
-32
-105
-119
-106
-227
-191
Net Profit Margin
2.85%
-38.05%
-91.93%
-130.44%
-75.20%
-170.55%
-175.89%
-69.47%
-366.62%
-186.45%

Sutro Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
31
-58
-48
-48
-72
-75
-11
-56
-46
Operating Cash Flow
14
-64
9
-64
-71
-67
-44
-38
-26
Investing Cash Flow
-23
64
-80
147
87
-16
2
39
18
Financing Cash Flow
-3
-3
96
1
0
0
0
0
0
Change in Cash
-12
-4
25
83
15
-84
-42
1
-7

Sutro Biopharma Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-19
-35
-55
-32
-105
-119
-106
-227
-191
Operating Cash Flow
-37
12
-65
-67
-81
3
-111
-191
-177
Investing Cash Flow
32
-80
-51
0
-97
-35
-3
218
45
Financing Cash Flow
14
170
-4
269
3
48
137
94
0
Change in Cash
10
103
-120
202
-175
16
22
121
-132

Global Institutional Holdings in Sutro Biopharma Inc

Funds
Holdings
Merck & Co Inc
1.64%
AQR Capital Management LLC
0.22%
UBS Group AG
1.11%
Samsara BioCapital, LLC
1.23%
Eversept Partners, LLC
2.7%
See all

Insights on Sutro Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -56.85M → -46.76M (in $), with an average increase of 21.6% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, STRO has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, STRO stock has moved up by 106.4%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 9.69M → 11.64M (in $), with an average increase of 16.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 51.1% return, outperforming this stock by 99.3%

About Sutro Biopharma Inc

at sutro biopharma we have pioneered a compelling and unique way of discovering, developing and manufacturing therapeutics. our focus is aimed primarily on next generation cancer therapeutics — antibody conjugates and bispecific antibodies. unconstrained by traditional methods of cell-based discovery, we can design and develop targeted medicines by innovating outside the constraints of the cell. our technology enables us to iteratively discover and test molecules in a rapid cycle of weeks rather than months, to rapidly identify the optimal molecule designed for safety and potency. our approach to discovery, without the cell, is also transcending the the limitations of biologics manufacturing. sutro has the world’s only cgmp cell-free manufacturing facility located in san carlos, california. this state-of- the-art facility confers an important competitive advantage as we head into human clinical trials in 2018. in addition to developing our own oncology pipeline, sutro biopharma is coll
OrganisationSutro Biopharma Inc
Headquarters111 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
IndustryHealth Technology
CEOMs. Jane Chung R.Ph.
E-voting on sharesClick here to vote

Key Management of Sutro Biopharma Inc

Name

Title

Mr. Edward C. Albini M.B.A

Secretary

Mr. Gregory K. Chow BA, CPA, MBA

Chief Financial Officer

Dr. Hans-Peter Gerber Ph.D.

Chief Scientific Officer

Ms. Kari E. Leetch

Senior VP and Head of People & Culture

Ms. Jane Chung R.Ph.

CEO & Director

Dr. James R. Swartz DSc, Ph.D., Sc.D.

Founder

Mr. Devendra Luhar

Senior Vice President of Technical Operations

Mr. David Pauling J.D., M.A.

Chief Administrative Officer & General Counsel

Ms. Regina Cheng

Vice President & Controller

Jonathan Fawcett DPHIL, MBBS

Vice President of Clinical Development

FAQs

What is Sutro Biopharma Inc share price today?

Sutro Biopharma Inc share price today is $23.72 as on at the close of the market. Sutro Biopharma Inc share today touched a day high of $25.39 and a low of $23.65.

What is the 52 week high and 52 week low for Sutro Biopharma Inc share?

Sutro Biopharma Inc share touched a 52 week high of $26.54 on and a 52 week low of $5.23 on . Sutro Biopharma Inc stock price today i.e. is closed at $23.72,which is 10.63% down from its 52 week high and 353.45% up from its 52 week low.

What is Sutro Biopharma Inc's market capitalisation today?

Sutro Biopharma Inc market capitalisation is $0.00T as on .

How to invest in Sutro Biopharma Inc Stock (STRO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sutro Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sutro Biopharma Inc Shares that will get you 0.0632 shares as per Sutro Biopharma Inc share price of $23.72 per share as on April 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy Sutro Biopharma Inc Stock (STRO) from India?

Indian investors can start investing in Sutro Biopharma Inc (STRO) shares with as little as ₹92.67 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.70 in Sutro Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Sutro Biopharma Inc share’s latest price of $23.72 as on April 3, 2026 at 1:29 am IST, you will get 0.4216 shares of Sutro Biopharma Inc. Learn more about fractional shares .

What are the returns that Sutro Biopharma Inc has given to Indian investors in the last 5 years?

Sutro Biopharma Inc stock has given -89.57% share price returns and 26.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?